Inari Medical, Inc. appears in FDA device records as an applicant and registered establishment rather than as a corporate parent or brand owner. The supplied filings link the name to premarket notification submissions for peripheral mechanical thrombectomy with aspiration and to an embolectomy catheter clearance, while the manufacturer's own website describes the FlowTriever system as purpose-built for pulmonary embolism treatment. The records below are dated submission examples, not a measure of total portfolio, sales or safety performance. [1][3][6]
Triever Duo Catheter clearance
FDA record K253419 identifies the Triever Duo Catheter, submitted by Inari Medical, Inc. of Irvine, California, with a date received of October 1, 2025 and a decision date of September 18, 2026. The decision code is SESE, described as substantially equivalent, under a Traditional clearance type with a Summary statement. The associated device description is peripheral mechanical thrombectomy with aspiration, product code QEW, regulation number 870.5150, device class 2, in the cardiovascular advisory committee. [1][6]
A third-party device record for the same submission lists the applicant, product code, decision date and decision in matching terms and states that the technological characteristics between the devices do not raise new or different questions of safety or effectiveness and support substantial equivalence to the predicate devices. That statement is the publisher's characterization of the clearance basis, not an independent clinical finding. [6]
FlowTriever2 Catheter clearance letter
A separate FDA clearance letter dated March 13, 2025 covers K250088 for the FlowTriever2 Catheter, addressed to Inari Medical, Inc. at 6001 Oak Canyon, Suite 100, Irvine, California. The letter lists regulation number 21 CFR 870.5150, regulation name Embolectomy Catheter, regulatory class II, and product codes QEW and KRA, with submission dates of January 13 and January 14, 2025. The letter directs readers to the Instructions for Use for detailed clinical study information. [8]
Manufacturer-published product documentation
Inari Medical's own website describes the FlowTriever Retrieval/Aspiration System as purpose-built for the treatment of pulmonary embolism, and the same site carries a notice that its product offerings are tailored for the United States only, with product availability and regulatory claims possibly varying in other regions. The site also describes the InThrill thrombectomy system as an 8F system designed to maximize thrombus removal and restore arteriovenous access without capital equipment, and references treatment of acute to chronic in-stent thrombosis. These are manufacturer statements about intended use and design, not verified outcomes. [3][4]
A ClotTriever system page on the same site describes the product in relation to removing large clots from large vessels and treating deep vein thrombosis. The site lists Inari Medical, Inc. headquarters at 6001 Oak Canyon, Suite 100, Irvine, California, and identifies Inari Medical Europe GmbH as a subsidiary with a Basel, Switzerland address. [7][4]
Registration and collection context
An FDA establishment registration and device listing record for registration number 3020347218 lists Inari Medical, Inc. in CA/USA with a current registration year of 2026, and a listing entry naming Triever16, Triever20, Triever20 Curve and Triever24 under a catheter, percutaneous product code. The linked collection contains one 510(k) record, with a decision count of one SESE and a sample decision count of one SESE across the single sampled record; these figures describe the linked filings only. [5][1]


